Loading stock data…
Amarin Corporation plc (AMRN)
$13.63-0.08 (-0.58%)
Pre-Market$13.70+0.07 (+0.51%)· Last close Sep 4
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Amarin Corporation plc in the Healthcare sector is trading at $13.63 with a market capitalization of $304M. Wall Street consensus targets $12.50 (2 analysts), implying a -8.3% move over the next 12 months. The stock is currently near its 52-week low of $12.96, remaining 7.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply -8.3% downside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $42.21M↓ | $45.13M↓ | $49.22M↓ | $49.67M↓ | $72.74M |
| Gross Profit | $14.99M↓ | $17.77M↓ | $23.17M↑ | $22.21M↓ | $50.36M |
| Operating Income | -$11.97M↓ | -$8.01M↓ | -$2.26M↓ | -$1.70M↓ | $6.77M |
| Net Income | -$7.65M↑ | -$10.51M↓ | -$1.22M↑ | -$7.74M↑ | -$14.14M |
Peer Comparison
JNJUNHPFE
Fundamentals
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$304.38M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.77
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-6.11%
Volume
Today's trading volume
80,559
Recent News
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
European equities traded in the US as American depositary receipts were trending slightly higher lat
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
European equities traded in the US as American depositary receipts were tracking lower late Wednesda
Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026
Amarin Corporation plc (NASDAQ:AMRN) will present new REDUCE-IT and EPA analyses at the European Society of Cardiology Congress 2026, adding further research around icosapent ethyl, cardiovascular risk factors and potential mechanisms associated with eicosapentaenoic acid. The presentations, scheduled for August 28 through August 30 during the Munich conference, will examine areas including treatment adherence, longer-term outcomes, lipoprotein(a), coagulation biomarkers and cellular pathways re
European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were edging lower late Wednesday
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
Tango Therapeutics stock falls 5% on a wider-than-expected Q2 loss, reflecting higher operating expenses, while pipeline progress remains in focus.